| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $142K | — | -66.6% |
| SG&A Expense | $663K | — | +7.9% |
| Operating Income | -$805K | — | +22.5% |
| Net Income | -$766K | — | +24.7% |
| EPS (Basic) | -$0.43 | — | -34.4% |
| EPS (Diluted) | -$0.43 | — | -34.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $5.0M | -14.1% | +57.5% |
| Total Assets | $5.0M | -14.1% | +57.5% |
| Current Liabilities | $309K | -26.1% | +23.2% |
| Total Liabilities | $309K | -26.1% | +23.2% |
| Stockholders' Equity | $4.7M | -13.2% | +60.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$804K | — | +13.2% |
| Financing Cash Flow | $348K | — | +0.0% |